论文部分内容阅读
目的研究硝普钠联合多巴胺对心力衰竭疾病的治疗价值。方法选取郑州市市直机关医院2014年1月—2015年11月住院接受治疗的83例心力衰竭疾病患者。患者分组方法:随机抽签法。83例患者分为常规抗心衰组和联合干预组两个组别。常规抗心衰组行心衰常规对症治疗;联合干预组加用硝普钠联合多巴胺治疗。观察指标:1心衰总疗效;2治疗前和治疗后患者呼吸、心率、舒张压、收缩压的差异。结果 1联合干预组相比于常规抗心衰组心衰总疗效更高,差异有统计学意义(P<0.05);2治疗前两组呼吸、心率、舒张压、收缩压相似,差异无统计学意义(P>0.05);治疗后联合干预组相比于常规抗心衰组呼吸、心率、舒张压、收缩压改善更显著,差异有统计学意义(P<0.05)。结论硝普钠联合多巴胺对心力衰竭疾病的治疗价值高,可有效改善患者临床症状和心率、血压等相关参数,对其预后有益。
Objective To study the therapeutic value of sodium nitroprusside combined with dopamine on heart failure. Methods Totally 83 patients with heart failure admitted to Zhengzhou Municipal Hospital from January 2014 to November 2015 were enrolled. Patient grouping method: Random lottery method. 83 patients were divided into two groups: conventional anti-heart failure group and combined intervention group. Conventional anti-heart failure group underwent conventional symptomatic treatment of heart failure; combined intervention group with sodium nitroprusside plus dopamine treatment. OUTCOME MEASURES: 1 The total efficacy of heart failure; 2 before treatment and after treatment, respiratory, heart rate, diastolic blood pressure, systolic blood pressure differences. Results 1 The combined intervention group compared with conventional anti-heart failure total efficacy of heart failure is higher, the difference was statistically significant (P <0.05); 2 before treatment two groups of breathing, heart rate, diastolic blood pressure, systolic blood pressure was similar, the difference was not statistically (P> 0.05). After treatment, respiration, heart rate, diastolic blood pressure and systolic blood pressure improved more significantly in the combined intervention group than those in the conventional anti-heart failure group, with significant difference (P <0.05). Conclusion Sodium nitroprusside combined with dopamine has high value in the treatment of heart failure disease, which can effectively improve the clinical symptoms, heart rate, blood pressure and other related parameters, and has a good prognosis.